|Day Low/High||17.13 / 17.80|
|52 Wk Low/High||12.30 / 25.53|
The rotation into blue-chip-like names is offsetting the tech exodus.
Understand the difference between growth-related overvaluation and mere froth.
Many investors don't give much thought to where their money goes.
We have to put these overvalued stocks into some perspective.
Let's tick down what hasn't gone wrong -- and what's making this market so resilient.
TheStreet's Jim Cramer is asked for advice on Mannkind, which has doubled in value after an FDA panel recommended approval of its insulin drug Afreeza.
TheStreet's Jim Cramer thinks the complaints will not affect Yelp and the decline may be as a result of pressure on many tech companies that went public at the same time.